Walk into any pet store, scroll through any pet supply website, or browse your social media feed and you'll encounter the same narrative: dogs are increasingly anxious, and supplements are the answer. L-theanine, chamomile, L-tryptophan, CBD, various proprietary blends. The message is consistent and pervasive: anxiety in dogs is a treatable condition, and these products represent a rational, safe solution.
This trend is being sold as inevitable. It deserves more skepticism than it is getting.
Don't misunderstand the point here. Anxiety in dogs is real. Dogs can experience genuine distress. The problem isn't acknowledging that. The problem is the uncritical embrace of a narrative that frames supplement consumption as the obvious, responsible path forward.
The supplement industry has masterfully rebranded what used to be a straightforward observation: some dogs are anxious. Now it's a market opportunity worth billions. And where there's a market opportunity, marketing follows. Pet owners see ads, read blog posts, encounter influencer recommendations, all suggesting that anxiety is both widespread and easily managed through the right product.
But here's what rarely gets discussed in these spaces: the actual evidence base is far thinner than the marketing would suggest. Yes, certain ingredients have been studied. Yes, some preliminary research exists. But the leap from "this compound showed some effect in a limited study" to "your dog probably needs this supplement" involves assumptions that deserve scrutiny.
Consider the framing itself. Pet owners are encouraged to identify anxiety in their dogs and then treat it. But how do we distinguish between normal canine behavior and pathological anxiety? Who defines the boundary? When a dog gets nervous during thunderstorms, is that anxiety requiring intervention, or is that a dog being a dog? The supplement industry benefits enormously from expanding the definition of what counts as a problem needing a solution.
There's also the question of regulation and quality control. Supplements operate in a different regulatory framework than medications. This means less rigorous testing, less standardization, fewer guarantees about what's actually in the bottle. A product labeled as containing chamomile might vary significantly in actual composition from another product with the same label. Pet owners often treat supplements as inherently safer than pharmaceuticals, but "natural" and "unregulated" aren't synonymous with "safe."
And then there's the broader behavioral question being sidestepped. Real anxiety in dogs sometimes requires behavioral modification, environmental changes, training, or veterinary care. These solutions require time, effort, and sometimes significant investment. A supplement is easier to recommend and easier to buy. It's attractive to both the pet industry and to pet owners seeking quick solutions.
The rise of pet insurance and the normalization of discussing pet mental health are positive developments in some ways. Pet owners should feel empowered to address their dogs' wellbeing. But that empowerment gets weaponized when it's channeled primarily toward consumption.
This isn't an argument against supplements universally. It's an argument for approaching them with genuine skepticism rather than the reflexive acceptance they often receive. It's an argument for asking harder questions: What does the actual evidence show? Who benefits from this narrative? Are there alternatives being overlooked? What am I not being told?
The supplement boom will continue because it's profitable and because marketing works. But we don't have to participate in it uncritically. Dog owners can care deeply about their pets' wellbeing while remaining suspicious of trends that conveniently align industry interests with consumer anxiety about pet health.
Your dog probably doesn't need as many supplements as you think. That's worth saying out loud.